Retracted: Lethal Disseminated Mucorales Infection With Positive Blood Cultures With Purpura Fulminans Complicating Hemophagocytic Lymphohistiocytosis After Chimeric Antigen Receptor T-Cell Therapy

Potential conflicts of interest. D. P. K. received research support from Gilead Sciences and Astellas Pharma; received consultant fees from Astellas Pharma, Merck, Matinas, Basilea, Knight, Inc, and Gilead Sciences; and is a member of the data review committee for Cidara Therapeutics, AbbVie, Scynexis, and the Mycoses Study Group. R. F. C. received consultant fees from ADMA Biologics, Janssen, Merck/MSD, Partner Therapeutics, Takeda, Shinogi, AiCuris, Roche/Genentech, Astellas, Adagio Therapeutics, Tether, Oxford Immunotec, Karius, Moderna, InflaRX, and Ansun Pharmaceuticals. All other authors report no potential conflicts.